Healthpeak Properties (NYSE:DOC) Upgraded to Hold at Wall Street Zen

Wall Street Zen upgraded shares of Healthpeak Properties (NYSE:DOC) from a sell rating to a hold rating in a research note issued to investors on Saturday.

DOC has been the topic of several other research reports. Jefferies Financial Group cut shares of Healthpeak Properties from a “buy” rating to a “hold” rating and lowered their price objective for the stock from $21.00 to $17.00 in a research note on Monday, December 15th. Cantor Fitzgerald set a $17.00 price target on shares of Healthpeak Properties in a research report on Monday, January 5th. Robert W. Baird cut their price objective on Healthpeak Properties from $21.00 to $20.00 and set an “outperform” rating for the company in a research report on Wednesday, November 12th. Evercore reduced their price objective on Healthpeak Properties from $21.00 to $19.00 and set an “outperform” rating for the company in a research note on Wednesday. Finally, Weiss Ratings raised Healthpeak Properties from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Monday, January 26th. Six investment analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $19.42.

Healthpeak Properties Stock Up 1.1%

Shares of DOC stock opened at $16.86 on Friday. Healthpeak Properties has a 1 year low of $15.71 and a 1 year high of $21.28. The stock has a market cap of $11.72 billion, a PE ratio of 168.62, a price-to-earnings-growth ratio of 9.04 and a beta of 1.12. The business’s fifty day moving average is $16.87 and its 200-day moving average is $17.59. The company has a debt-to-equity ratio of 1.21, a quick ratio of 1.22 and a current ratio of 2.82.

Healthpeak Properties (NYSE:DOC) last announced its quarterly earnings data on Monday, February 2nd. The real estate investment trust reported $0.47 earnings per share for the quarter, beating the consensus estimate of $0.45 by $0.02. The business had revenue of $719.40 million during the quarter, compared to analyst estimates of $685.14 million. Healthpeak Properties had a return on equity of 0.84% and a net margin of 2.52%.The company’s revenue was up 3.1% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.46 earnings per share. Healthpeak Properties has set its FY 2026 guidance at 1.700-1.740 EPS. Equities analysts expect that Healthpeak Properties will post 1.86 earnings per share for the current fiscal year.

Healthpeak Properties Announces Dividend

The firm also recently announced a monthly dividend, which will be paid on Tuesday, March 31st. Stockholders of record on Tuesday, March 17th will be issued a $0.1017 dividend. The ex-dividend date is Tuesday, March 17th. This represents a c) dividend on an annualized basis and a dividend yield of 7.2%. Healthpeak Properties’s dividend payout ratio is presently 1,220.00%.

Institutional Investors Weigh In On Healthpeak Properties

Several hedge funds have recently bought and sold shares of DOC. JPMorgan Chase & Co. grew its stake in Healthpeak Properties by 41.0% during the 3rd quarter. JPMorgan Chase & Co. now owns 28,236,534 shares of the real estate investment trust’s stock valued at $540,730,000 after acquiring an additional 8,212,504 shares in the last quarter. Norges Bank purchased a new position in Healthpeak Properties during the second quarter valued at approximately $140,558,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its stake in Healthpeak Properties by 694.6% in the 3rd quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 8,016,692 shares of the real estate investment trust’s stock valued at $153,520,000 after buying an additional 7,007,777 shares during the period. Nordea Investment Management AB lifted its position in Healthpeak Properties by 7,444.0% in the 2nd quarter. Nordea Investment Management AB now owns 3,923,205 shares of the real estate investment trust’s stock worth $67,871,000 after buying an additional 3,871,201 shares in the last quarter. Finally, Equity Investment Corp lifted its position in Healthpeak Properties by 209.6% in the 3rd quarter. Equity Investment Corp now owns 5,330,948 shares of the real estate investment trust’s stock worth $102,088,000 after buying an additional 3,608,849 shares in the last quarter. 93.57% of the stock is owned by hedge funds and other institutional investors.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.